Biomarkers in the prognostic evaluation of ischemic stroke : is there benefit in the measurements of TREM-1 and TREM-2 in the acute phase?
dc.contributor.author | Backes, Fabiane Neiva | pt_BR |
dc.contributor.author | Souza, Andressa de | pt_BR |
dc.contributor.author | Bianchin, Marino Muxfeldt | pt_BR |
dc.date.accessioned | 2022-01-27T04:30:40Z | pt_BR |
dc.date.issued | 2021 | pt_BR |
dc.identifier.uri | http://hdl.handle.net/10183/234479 | pt_BR |
dc.format.mimetype | application/pdf | pt_BR |
dc.language.iso | eng | pt_BR |
dc.relation.ispartof | Intensive care medicine. New York | pt_BR |
dc.rights | Open Access | en |
dc.subject | Neurologia | pt_BR |
dc.title | Biomarkers in the prognostic evaluation of ischemic stroke : is there benefit in the measurements of TREM-1 and TREM-2 in the acute phase? | pt_BR |
dc.type | Resumo publicado em evento | pt_BR |
dc.contributor.event | ESICM Lives (34 : 2021 : New York) | pt_BR |
dc.identifier.nrb | 001135583 | pt_BR |
dc.type.origin | Estrangeiro | pt_BR |
Files in this item
This item is licensed under a Creative Commons License
![](/themes/Mirage2Novo//images/lume/cc.png)
-
Health Sciences (17773)